ReCode Therapeutics

ReCode Therapeutics is a clinical-stage genetic medicines company headquartered in Menlo Park, California with operations in Dallas, Texas, founded in 2015 out of research at UT Southwestern. Its Selective Organ Targeting (SORT) lipid nanoparticle platform is a delivery technology that directs mRNA and gene-correction payloads to organs, tissues and cells beyond the liver — the constraint that has limited genetic medicines to date — with redosing capability. Its lead programmes are RCT1100, an inhaled DNAI1 mRNA therapy for primary ciliary dyskinesia which has reported first-ever proof of activity in PCD patients, and RCT2100, an inhaled CFTR mRNA therapy for cystic fibrosis now in a Phase 2 combination trial with ivacaftor; both hold U.S. FDA Orphan Drug designation. The company collaborates with Intellia Therapeutics on CRISPR-based gene correction for cystic fibrosis, is funded in part by the Cystic Fibrosis Foundation, and has raised over $260 million in Series B financing. ReCode Therapeutics runs no developer program and publishes no product API, developer portal or API documentation; the only machine-readable surface reachable without credentials is the WordPress REST content API behind recodetx.com, catalogued here alongside the llms.txt the site publishes.

ReCode Therapeutics publishes 7 APIs on the APIs.io network, including Content API, Discovery API, Embed API, and 4 more. Tagged areas include Company, genetic-medicines, biotechnology, biopharmaceuticals, and mrna.

The ReCode Therapeutics catalog on APIs.io includes 1 JSON-LD context.

ReCode Therapeutics’ developer surface includes product news, authentication, and 31 more developer resources.

30.7/100 thin ▬ flat Agent 30/100 agent aware Full breakdown ↓
scored 2026-08-12 · rubric v0.11.0
7 APIs
Companygenetic-medicinesbiotechnologybiopharmaceuticalsmrnagene-correctionlipid-nanoparticlesdrug-deliveryrare-diseasecystic-fibrosisprimary-ciliary-dyskinesiaclinical-trialslife-sciencescontent-api

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-08-12 · rubric v0.11.0
Composite quality — 30.7/100 · thin
Contract Quality 12.2 / 21
Developer Ergonomics 2.1 / 17
Commercial Clarity 3.6 / 17
Operational Transparency 0.0 / 11
Governance 1.2 / 10
Discoverability 6.9 / 9
Regulatory Posture 4.7 / 15
Agent readiness — 30/100 · agent aware
Machine-Readable Contract 18 / 18
Agentic Access Contract 0 / 10
MCP Server 0 / 12
Machine-Readable Auth 10 / 10
Idempotency 0 / 9
Stable Error Semantics 8 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 5 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
A2A Agent Card 0 / 8
Dry-Run / Simulate Mode 0 / 4
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/recode-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

APIs 7

Individual APIs this provider publishes, each with its own machine-readable definition.

ReCode Therapeutics Content API

Press releases, publications, corporate pages and site-specific custom post types.

ReCode Therapeutics Discovery API

Route index and namespace metadata the install publishes about itself.

ReCode Therapeutics Embed API

oEmbed 1.0 provider endpoint for recodetx.com URLs.

ReCode Therapeutics Media API

The media library — images, PDFs, posters and decks attached to the site.

ReCode Therapeutics People API

Author records. Personal data — read the x-personal-data annotation before use.

ReCode Therapeutics Search API

Cross-content search across every REST-exposed post type.

ReCode Therapeutics Taxonomy API

Categories, tags, and the registered type/status/taxonomy descriptors.

Scroll for all 7

Semantic Vocabularies 1

JSON-LD contexts and semantic vocabularies used across these APIs.

Recode Therapeutics Organization Context

0 classes · 0 properties

JSON-LD

Security Posture 2

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Recode Therapeutics Domain Security

TLSv1.3 · DMARC

SECURITY

Resources

Agent Surfaces 3

MCP servers, agent skills, and machine-readable catalogs

Design & Contract 6

Pagination, idempotency, versioning, errors, and events

Build 2

SDKs, sample code, and the tooling you integrate with

Access & Security 2

Authentication, authorization, and security posture

Commercial 2

Pricing, plans, and the legal terms of use

Company 9

The organization behind the API

Scroll for all 9

Other 9

Properties that don't map to a standard resource type

Scroll for all 9

Source (apis.yml)

apis.yml Raw ↑
aid: recode-therapeutics
name: ReCode Therapeutics
description: ReCode Therapeutics is a clinical-stage genetic medicines company headquartered in Menlo Park, California with
  operations in Dallas, Texas, founded in 2015 out of research at UT Southwestern. Its Selective Organ Targeting (SORT) lipid
  nanoparticle platform is a delivery technology that directs mRNA and gene-correction payloads to organs, tissues and cells
  beyond the liver — the constraint that has limited genetic medicines to date — with redosing capability. Its lead programmes
  are RCT1100, an inhaled DNAI1 mRNA therapy for primary ciliary dyskinesia which has reported first-ever proof of activity
  in PCD patients, and RCT2100, an inhaled CFTR mRNA therapy for cystic fibrosis now in a Phase 2 combination trial with ivacaftor;
  both hold U.S. FDA Orphan Drug designation. The company collaborates with Intellia Therapeutics on CRISPR-based gene correction
  for cystic fibrosis, is funded in part by the Cystic Fibrosis Foundation, and has raised over $260 million in Series B financing.
  ReCode Therapeutics runs no developer program and publishes no product API, developer portal or API documentation; the only
  machine-readable surface reachable without credentials is the WordPress REST content API behind recodetx.com, catalogued
  here alongside the llms.txt the site publishes.
image: https://recodetx.com/wp-content/uploads/2022/06/ReCode_Logo_Primary_Web.svg
url: https://raw.githubusercontent.com/api-evangelist/recode-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: profiled
x-tier-reason: enriched
specificationVersion: '0.20'
created: '2026-08-05'
modified: '2026-08-05'
tags:
- Company
- genetic-medicines
- biotechnology
- biopharmaceuticals
- mrna
- gene-correction
- lipid-nanoparticles
- drug-delivery
- rare-disease
- cystic-fibrosis
- primary-ciliary-dyskinesia
- clinical-trials
- life-sciences
- content-api
apis:
- aid: recode-therapeutics:recode-therapeutics-content-api
  name: ReCode Therapeutics Content API
  description: Press releases, publications, corporate pages and site-specific custom post types.
  humanURL: https://developer.wordpress.org/rest-api/
  baseURL: https://recodetx.com/wp-json
  tags:
  - content
  properties:
  - type: OpenAPI
    url: openapi/recode-therapeutics-content-api-openapi.yml
  - type: Authentication
    url: authentication/recode-therapeutics-authentication.yml
  - type: ErrorCatalog
    url: errors/recode-therapeutics-problem-types.yml
  - type: Conventions
    url: conventions/recode-therapeutics-conventions.yml
  - type: DataModel
    url: data-model/recode-therapeutics-data-model.yml
  - type: Lifecycle
    url: lifecycle/recode-therapeutics-lifecycle.yml
- aid: recode-therapeutics:recode-therapeutics-discovery-api
  name: ReCode Therapeutics Discovery API
  description: Route index and namespace metadata the install publishes about itself.
  humanURL: https://developer.wordpress.org/rest-api/
  baseURL: https://recodetx.com/wp-json
  tags:
  - discovery
  properties:
  - type: OpenAPI
    url: openapi/recode-therapeutics-discovery-api-openapi.yml
  - type: Authentication
    url: authentication/recode-therapeutics-authentication.yml
  - type: ErrorCatalog
    url: errors/recode-therapeutics-problem-types.yml
  - type: Conventions
    url: conventions/recode-therapeutics-conventions.yml
  - type: DataModel
    url: data-model/recode-therapeutics-data-model.yml
  - type: Lifecycle
    url: lifecycle/recode-therapeutics-lifecycle.yml
- aid: recode-therapeutics:recode-therapeutics-embed-api
  name: ReCode Therapeutics Embed API
  description: oEmbed 1.0 provider endpoint for recodetx.com URLs.
  humanURL: https://developer.wordpress.org/rest-api/
  baseURL: https://recodetx.com/wp-json
  tags:
  - embed
  properties:
  - type: OpenAPI
    url: openapi/recode-therapeutics-embed-api-openapi.yml
  - type: Authentication
    url: authentication/recode-therapeutics-authentication.yml
  - type: ErrorCatalog
    url: errors/recode-therapeutics-problem-types.yml
  - type: Conventions
    url: conventions/recode-therapeutics-conventions.yml
  - type: DataModel
    url: data-model/recode-therapeutics-data-model.yml
  - type: Lifecycle
    url: lifecycle/recode-therapeutics-lifecycle.yml
- aid: recode-therapeutics:recode-therapeutics-media-api
  name: ReCode Therapeutics Media API
  description: The media library — images, PDFs, posters and decks attached to the site.
  humanURL: https://developer.wordpress.org/rest-api/
  baseURL: https://recodetx.com/wp-json
  tags:
  - media
  properties:
  - type: OpenAPI
    url: openapi/recode-therapeutics-media-api-openapi.yml
  - type: Authentication
    url: authentication/recode-therapeutics-authentication.yml
  - type: ErrorCatalog
    url: errors/recode-therapeutics-problem-types.yml
  - type: Conventions
    url: conventions/recode-therapeutics-conventions.yml
  - type: DataModel
    url: data-model/recode-therapeutics-data-model.yml
  - type: Lifecycle
    url: lifecycle/recode-therapeutics-lifecycle.yml
- aid: recode-therapeutics:recode-therapeutics-people-api
  name: ReCode Therapeutics People API
  description: Author records. Personal data — read the x-personal-data annotation before use.
  humanURL: https://developer.wordpress.org/rest-api/
  baseURL: https://recodetx.com/wp-json
  tags:
  - people
  properties:
  - type: OpenAPI
    url: openapi/recode-therapeutics-people-api-openapi.yml
  - type: Authentication
    url: authentication/recode-therapeutics-authentication.yml
  - type: ErrorCatalog
    url: errors/recode-therapeutics-problem-types.yml
  - type: Conventions
    url: conventions/recode-therapeutics-conventions.yml
  - type: DataModel
    url: data-model/recode-therapeutics-data-model.yml
  - type: Lifecycle
    url: lifecycle/recode-therapeutics-lifecycle.yml
- aid: recode-therapeutics:recode-therapeutics-search-api
  name: ReCode Therapeutics Search API
  description: Cross-content search across every REST-exposed post type.
  humanURL: https://developer.wordpress.org/rest-api/
  baseURL: https://recodetx.com/wp-json
  tags:
  - search
  properties:
  - type: OpenAPI
    url: openapi/recode-therapeutics-search-api-openapi.yml
  - type: Authentication
    url: authentication/recode-therapeutics-authentication.yml
  - type: ErrorCatalog
    url: errors/recode-therapeutics-problem-types.yml
  - type: Conventions
    url: conventions/recode-therapeutics-conventions.yml
  - type: DataModel
    url: data-model/recode-therapeutics-data-model.yml
  - type: Lifecycle
    url: lifecycle/recode-therapeutics-lifecycle.yml
- aid: recode-therapeutics:recode-therapeutics-taxonomy-api
  name: ReCode Therapeutics Taxonomy API
  description: Categories, tags, and the registered type/status/taxonomy descriptors.
  humanURL: https://developer.wordpress.org/rest-api/
  baseURL: https://recodetx.com/wp-json
  tags:
  - taxonomy
  properties:
  - type: OpenAPI
    url: openapi/recode-therapeutics-taxonomy-api-openapi.yml
  - type: Authentication
    url: authentication/recode-therapeutics-authentication.yml
  - type: ErrorCatalog
    url: errors/recode-therapeutics-problem-types.yml
  - type: Conventions
    url: conventions/recode-therapeutics-conventions.yml
  - type: DataModel
    url: data-model/recode-therapeutics-data-model.yml
  - type: Lifecycle
    url: lifecycle/recode-therapeutics-lifecycle.yml
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Overlay
  url: overlays/recode-therapeutics-content-overlay.yaml
- type: DomainSecurity
  url: security/recode-therapeutics-domain-security.yml
- type: Website
  url: https://recodetx.com/
- type: About
  url: https://recodetx.com/about/
- type: Science
  url: https://recodetx.com/science/
- type: Pipeline
  url: https://recodetx.com/pipeline/
- type: ClinicalStudies
  url: https://recodetx.com/clinical-studies/
- type: Patients
  url: https://recodetx.com/patients/
- type: Partnering
  url: https://recodetx.com/partnering/
- type: Leadership
  url: https://recodetx.com/leadership/
- type: Careers
  url: https://recodetx.com/careers-culture/
- type: News
  url: https://recodetx.com/news/
- type: BlogRSS
  url: https://recodetx.com/feed/
- type: Events
  url: https://recodetx.com/events/
- type: MediaLibrary
  url: https://recodetx.com/media-library/
- type: TermsOfService
  url: https://recodetx.com/terms-conditions/
- type: PrivacyPolicy
  url: https://recodetx.com/privacy-policy/
- type: CookiePolicy
  url: https://recodetx.com/cookie-policy/
- type: LinkedIn
  url: https://www.linkedin.com/company/recode-therapeutics/
- type: Twitter
  url: https://twitter.com/ReCodeTx
- type: Instagram
  url: https://www.instagram.com/recodetx/
- type: Sitemap
  url: https://recodetx.com/sitemap.xml
- type: SecondaryMarket
  url: https://forgeglobal.com/recode-therapeutics_stock/
- type: LLMsTxt
  url: llms/recode-therapeutics-llms.txt
- type: WellKnown
  url: well-known/recode-therapeutics-well-known.yml
- type: Authentication
  url: authentication/recode-therapeutics-authentication.yml
- type: Conventions
  url: conventions/recode-therapeutics-conventions.yml
- type: Conformance
  url: conformance/recode-therapeutics-conformance.yml
- type: ErrorCatalog
  url: errors/recode-therapeutics-problem-types.yml
- type: Lifecycle
  url: lifecycle/recode-therapeutics-lifecycle.yml
- type: DataModel
  url: data-model/recode-therapeutics-data-model.yml
- type: JSONLD
  url: json-ld/recode-therapeutics-json-ld.yml
- type: AgentSkill
  url: skills/_index.yml
x-enrichment:
  date: '2026-08-05'
  status: enriched
  artifacts_added: 17
  pass: local-v1